Endurance Wealth Management, Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Endurance Wealth Management, Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2023$5
+25.0%
1650.0%0.00%0.0%
Q1 2023$4
+33.3%
1650.0%0.00%
Q4 2022$3
-99.8%
1650.0%0.00%
Q3 2022$2,000
-33.3%
1650.0%0.00%
Q2 2022$3,000
-25.0%
1650.0%0.00%
-100.0%
Q1 2022$4,000
-33.3%
1650.0%0.00%0.0%
Q4 2021$6,000
-25.0%
1650.0%0.00%0.0%
Q3 2021$8,000
+60.0%
1650.0%0.00%0.0%
Q2 2021$5,000
-28.6%
1650.0%0.00%0.0%
Q1 2021$7,0001650.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders